These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7546695)

  • 21. [Proxodolol, a new domestic preparation for lowering intraocular pressure in glaucoma].
    Ermakova VN; Iuzhakov SD; Mashkovskiĭ MD; Kolomoĭtseva EM
    Vestn Oftalmol; 1995; 111(2):4-7. PubMed ID: 7645180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prospects of using latanoprost, prostaglandin F2 alpha analog, in hypotensive therapy for glaucoma].
    Egorov EA; Nesterov AP; Romanova OV
    Vestn Oftalmol; 1998; 114(4):19-20. PubMed ID: 9771080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of nasolacrimal canal blockage on topical medications for glaucoma.
    Aritürk N; Oge I; Erkan D; Süllü Y; Sahin M
    Acta Ophthalmol Scand; 1996 Aug; 74(4):411-3. PubMed ID: 8883562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Xalathane: comparative assessment of efficacy and safety in hypotensive therapy of glaucoma].
    Erichev VP; Iakubova LV
    Vestn Oftalmol; 1998; 114(4):20-1. PubMed ID: 9771081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pressure-reducing efficacy and tolerability of betaxolol in ionic solution.
    Troiano P; Cavallotti B; Iraci M; Galli L; Miglior M
    Acta Ophthalmol Scand Suppl; 1997; (224):18-20. PubMed ID: 9589712
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%.
    Sihota R; Agarwal HC; Rajashekar YL
    Indian J Ophthalmol; 1996 Jun; 44(2):87-9. PubMed ID: 8916595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The intraocular pressure depressive effect of puerarin].
    Kang RX
    Zhonghua Yan Ke Za Zhi; 1993 Nov; 29(6):336-9. PubMed ID: 7912669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic β-Blockers Do Not Affect Glaucoma Eye Drop Effectiveness.
    Johnson TV; Jampel HD
    Ophthalmology; 2021 Feb; 128(2):326-328. PubMed ID: 32622847
    [No Abstract]   [Full Text] [Related]  

  • 29. The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.
    Diestelhorst M
    Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):433-9. PubMed ID: 10901475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of once-daily levobunolol on intraocular pressure in normal-tension glaucoma.
    Inoue K; Ezure T; Wakakura M; Inoue J; Tomita G
    Jpn J Ophthalmol; 2005; 49(1):58-9. PubMed ID: 15692777
    [No Abstract]   [Full Text] [Related]  

  • 31. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
    J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which patients are treated for glaucoma? An observational analysis.
    Bohn RL; Gurwitz JH; Yeomans SM; Glynn RJ; Pasquale LR; Walker AM; Avorn J
    J Glaucoma; 2000 Feb; 9(1):38-44. PubMed ID: 10708230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of dapiprazole, an alpha-adrenergic blocking agent, in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmic Surg Lasers; 1996 Sep; 27(9):806-9. PubMed ID: 8878205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of glaucoma medications on ocular surface disease in primary open-angle glaucoma patients with and without conjunctivochalasis.
    Kocabeyoglu S; Mocan MC; Irkec M
    Acta Ophthalmol; 2014 Nov; 92(7):e592-3. PubMed ID: 24774884
    [No Abstract]   [Full Text] [Related]  

  • 35. Double-blind cross-over comparison of aceclidine and pilocarpine in open-angle glaucoma.
    Romano JH
    Br J Ophthalmol; 1970 Aug; 54(8):510-21. PubMed ID: 4917903
    [No Abstract]   [Full Text] [Related]  

  • 36. Validation of a questionnaire for comparing the tolerability of ophthalmic medications.
    Barber BL; Strahlman ER; Laibovitz R; Guess HA; Reines SA
    Ophthalmology; 1997 Feb; 104(2):334-42. PubMed ID: 9052642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual glaucoma and miotics: treatment after relief of malignant glaucoma by vitreous puncture and aspiration.
    Macoul KL
    Arch Ophthalmol; 1972 Aug; 88(2):210-1. PubMed ID: 5045499
    [No Abstract]   [Full Text] [Related]  

  • 38. [Primary open-angle glaucoma. Effects of an eyedrop combining timolol and pilocarpine on the ocular pressure].
    Leroy C; Collignon-Brach J
    J Fr Ophtalmol; 1990; 13(1-2):29-32. PubMed ID: 2212504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient selection in the Timpilo Study.
    Loewenstein A; Lazar M
    Arch Ophthalmol; 1993 Oct; 111(10):1313. PubMed ID: 8280287
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
    Nordmann JP; Söderström M; Rouland JF; Malecaze F
    Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.